论文部分内容阅读
依博巴胺(ibopamine)是一新的口服速效多巴胺类药物。本研究用之治疗20例慢性肾功能衰竭(慢肾衰)患者,其中男12例,女8例,年龄21～64(平均41.1)岁。所有病例均符合下列指标:①慢肾衰由原发性肾脏病所致;②确已有慢肾衰且无高血压
Ibbopamine is a new oral fast-acting dopamine drug. This study was used to treat 20 patients with chronic renal failure (chronic renal failure), including 12 males and 8 females, aged from 21 to 64 (average 41.1) years. All cases are in line with the following indicators: ① slow renal failure caused by primary kidney disease; ② indeed have slow renal failure and no high blood pressure